Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -80.18x is 267% below its 5-year average of -21.85x, around the middle of its 5-year range (-246.94x–21.79x).
463.45% below its 12-month average of -14.23x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -21.14x.
INTEREST COVERAGE RATIO
-80.18x
INTEREST COVERAGE RATIO AVG TTM
-14.23x
INTEREST COVERAGE RATIO AVG 3Y
-22.43x
INTEREST COVERAGE RATIO AVG 5Y
-21.85x
INTEREST COVERAGE RATIO AVG 10Y
-28.40x
INTEREST COVERAGE RATIO AVG 15Y
-27.31x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-463.45%
CURRENT VS 3Y AVG
-257.40%
CURRENT VS 5Y AVG
-266.97%
CURRENT VS 10Y AVG
-182.32%
CURRENT VS 15Y AVG
-193.58%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 520 covered companies
CURRENT VS SECTOR MEDIAN
-1157.73%
vs the sector median at left
Pacific Biosciences of California, Inc.
Market Cap
$844.84M
Interest Coverage Ratio
-80.18x
TTM Avg
-14.23x
3Y Avg
-22.43x
5Y Avg
-21.85x
Market Cap
$849.66M
Interest Coverage Ratio
-5.18x
TTM Avg
6.05x
3Y Avg
536.48x
5Y Avg
359.36x
Market Cap
$836.98M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$834.16M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$837.03M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$855.16M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$860.37M
Interest Coverage Ratio
17.14x
TTM Avg
10.10x
3Y Avg
10.10x
5Y Avg
10.10x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacific Biosciences of California, Inc. (PACB) | $844.84M | -80.18x | -14.23x | -22.43x | -21.85x |
| QuidelOrtho Corporation (QDEL)vs › | $849.66M | -5.18x | 6.05x | 536.48x | 359.36x |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $836.98M | N/A | N/A | N/A | N/A |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $834.16M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $837.03M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $833.23M | N/A | N/A | N/A | N/A |
| SL Science Holding Ltd (SLBT)vs › | $855.16M | N/A | N/A | N/A | N/A |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $860.37M | 17.14x | 10.10x | 10.10x | 10.10x |
| SI-BONE, Inc. (SIBN)vs › | $859.52M | -4.23x | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $866.51M | N/A | N/A | N/A | N/A |
Interest Coverage
-80.2x
Debt/Equity
N/A
Current Ratio
4.92
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -21.14x |
| 2026-03-31 | 21.79x |
| 2025-12-31 | -23.68x |
| 2025-09-30 | -22.32x |
| 2025-06-30 | -25.81x |
| 2025-03-31 | -246.94x |
| 2024-12-31 | -55.51x |
| 2024-09-30 | -18.11x |
| 2024-06-30 | -49.65x |
| 2024-03-31 | -22.76x |
| 2023-12-31 | -24.52x |
| 2023-09-30 | -22.99x |
| 2023-06-30 | -20.59x |
| 2023-03-31 | -25.14x |
| 2022-12-31 | -23.87x |
| 2022-09-30 | -20.37x |
| 2022-06-30 | -18.46x |
| 2022-03-31 | -20.97x |
| 2021-12-31 | -18.59x |
| 2021-09-30 | -20.28x |
| 2021-06-30 | -10.47x |
| 2021-03-31 | -18.84x |
| 2020-03-31 | -122.51x |
| 2019-12-31 | -26.43x |
| 2019-09-30 | -42.34x |
| 2019-06-30 | -37.86x |
| 2019-03-31 | -48.21x |
| 2018-12-31 | -48.76x |
| 2018-09-30 | -40.05x |
| 2018-06-30 | -36.36x |
| 2018-03-31 | -41.22x |
| 2017-12-31 | -32.90x |
| 2017-09-30 | -34.07x |
| 2017-06-30 | -29.52x |
| 2017-03-31 | -27.80x |
| 2016-12-31 | -21.30x |
| 2016-09-30 | -20.38x |
| 2016-06-30 | -22.73x |
| 2016-03-31 | -23.83x |
| 2015-12-31 | -1.37x |
| 2015-09-30 | 3.53x |
| 2015-06-30 | -15.89x |
| 2015-03-31 | -27.73x |
| 2014-12-31 | -24.68x |
| 2014-09-30 | -11.75x |
| 2014-06-30 | -26.11x |
| 2014-03-31 | -26.60x |
| 2013-12-31 | -24.54x |
| 2013-09-30 | -29.06x |
| 2013-06-30 | -29.71x |
| 2013-03-31 | -48.37x |
| 2012-09-30 | -332.04x |
| 2012-06-30 | -326.88x |
| 2010-09-30 | -13565.33x |
| 2010-03-31 | -738.39x |